Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Diagnosis (PGD) is a reproductive technology used to screen embryos for genetic abnormalities before they are implanted in the uterus during in vitro fertilization (IVF). PGD enables couples at risk of passing on genetic disorders to conceive embryos that are free from the specific genetic condition they carry. It also raises complex ethical considerations related to embryo selection, non-medical applications, access to care, and reproductive autonomy.
Applications of Preimplantation Genetic Diagnosis (PGD) includes
- Prevention of genetic disorders
- Family balancing
- Reduced risk of genetic disorders
- Increased pregnancy success rates
Related Conference of Preimplantation Genetic Diagnosis (PGD)
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Preimplantation Genetic Diagnosis (PGD) Conference Speakers
Recommended Sessions
- Bioethics and Genomic Research
- Bioinformatics
- Cancer Genomics
- Cognitive Computing
- Computational Biology
- Drug Detection & Development in Bioinformatics
- Education and Training in Genomic Medicine
- Emergency Genomic Medicine
- Epigenetics Biomarkers
- Genes and Immunology
- Genetically Modified Organisms
- Genome Mapping
- Genomic Approach to Drug Discovery
- Genomic Medicine
- Genomic Technologies in Forensic Science
- Genomic Vaccination
- Human Gene Therapy
- Human Genetics and Genomics
- Infectious Diseases
- Pharma Genomics & Pharma Informatics
- Preimplantation Genetic Diagnosis (PGD)
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)